In summary, ISM1 upregulation and overexpression are reported in multiple cancers, including gastric cancer, hepatocellular carcinoma (HCC), colon adenocarcinoma, and colorectal cancer, while ISM2 overexpression was reported in choriocarcinoma. Here, ISM2 is linked to choriocarcinoma.